AFP and Dravet syndrome: Second-trimester serological screening like the double or triple tests, identifies biochemical markers in maternal serum— namely alpha-fetoprotein, free beta-human chorionic gonadotropin, and unconjugated estriol— and combines these with maternal age and gestational age to estimate DS risk (30).